The lawsuit, filed in the U.S. District Court for the District of Columbia, alleges that Cogent and its executives misled shareholders by inflating the viability of its optical wavelength backlog. According to the complaint, the company claimed a substantial backlog of orders while failing to disclose that many customers were either unable or unwilling to accept delivery. These internal pressures culminated in a dramatic reversal of the company’s long-standing dividend policy, which was slashed by 98% in late 2025.

Throughout the class period, Cogent’s stock price suffered repeated sharp declines following quarterly earnings reports that consistently missed growth targets. Investors seeking to serve as lead plaintiff in the litigation have until September 21, 2026, to file their applications. The legal action centers on accusations that CEO David Schaeffer and other top officers disregarded financial realities and engaged in high-risk stock pledging, further destabilizing the company’s market position as the true state of its revenue and customer demand was revealed.